Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau

BACKGROUND: Children in Guinea-Bissau receive measles vaccine (MV) at 9 months of age, but studies have shown that an additional dose before 9 months of age might have beneficial nonspecific effects. Within a randomized trial designed to examine nonspecific effects of early MV receipt on mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Vu An, Biering-Sørensen, Sofie, Fisker, Ane Bærent, Balé, Carlito, Rasmussen, Stine Møller, Christensen, Lone Damkjær, Jensen, Kristoffer Jarlov, Martins, Cesário, Aaby, Peter, Benn, Christine Stabell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441109/
https://www.ncbi.nlm.nih.gov/pubmed/28077730
http://dx.doi.org/10.1093/infdis/jiw512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441109/
https://www.ncbi.nlm.nih.gov/pubmed/28077730
http://dx.doi.org/10.1093/infdis/jiw512

Ejemplares similares